Yan Ma

2.8k total citations · 1 hit paper
74 papers, 2.2k citations indexed

About

Yan Ma is a scholar working on Molecular Biology, Biomedical Engineering and Biomaterials. According to data from OpenAlex, Yan Ma has authored 74 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 15 papers in Biomedical Engineering and 12 papers in Biomaterials. Recurrent topics in Yan Ma's work include Nanoplatforms for cancer theranostics (13 papers), Nanoparticle-Based Drug Delivery (12 papers) and Drug Solubulity and Delivery Systems (5 papers). Yan Ma is often cited by papers focused on Nanoplatforms for cancer theranostics (13 papers), Nanoparticle-Based Drug Delivery (12 papers) and Drug Solubulity and Delivery Systems (5 papers). Yan Ma collaborates with scholars based in China, United States and Australia. Yan Ma's co-authors include Jeanne Drisko, Julia Chapman, Mark Levine, Qi Chen, Kishore Polireddy, Zhonggui He, Yongjun Wang, Shu G. Chen, Amy L. Wilson‐Delfosse and George Perry and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Nano Letters.

In The Last Decade

Yan Ma

72 papers receiving 2.2k citations

Hit Papers

High-Dose Parenteral Asco... 2014 2026 2018 2022 2014 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. High-Dose Parenteral Ascorbate Enhanced Chemosensitivity of Ovarian Cancer and Reduced Toxicity of Chemotherapy
    2014 374 citations Yan Ma, Jeanne Drisko et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yan Ma China 23 916 545 507 289 246 74 2.2k
Yu Ishima Japan 34 2.0k 2.1× 473 0.9× 612 1.2× 200 0.7× 195 0.8× 143 4.0k
Barbara Marengo Italy 28 1.4k 1.5× 305 0.6× 217 0.4× 143 0.5× 208 0.8× 66 2.6k
Yi Feng China 29 1.1k 1.2× 358 0.7× 249 0.5× 227 0.8× 97 0.4× 92 2.2k
Yongmei Xie China 35 1.6k 1.7× 342 0.6× 253 0.5× 161 0.6× 477 1.9× 159 3.7k
Yunxiang Zhou China 20 784 0.9× 468 0.9× 492 1.0× 41 0.1× 232 0.9× 43 2.1k
Francesca Re Italy 36 1.6k 1.8× 600 1.1× 1.1k 2.1× 94 0.3× 437 1.8× 123 4.2k
Heather Hatcher United States 18 1.5k 1.6× 593 1.1× 324 0.6× 446 1.5× 345 1.4× 23 3.9k
Kaoxiang Sun China 34 1.4k 1.6× 889 1.6× 1.2k 2.3× 87 0.3× 251 1.0× 107 3.7k
Hongmei Li China 29 2.2k 2.4× 318 0.6× 256 0.5× 132 0.5× 138 0.6× 116 3.1k
Chiara Martinelli Italy 22 916 1.0× 469 0.9× 346 0.7× 99 0.3× 231 0.9× 50 2.3k

Countries citing papers authored by Yan Ma

Since Specialization
Citations

This map shows the geographic impact of Yan Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yan Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yan Ma more than expected).

Fields of papers citing papers by Yan Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yan Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yan Ma. The network helps show where Yan Ma may publish in the future.

Co-authorship network of co-authors of Yan Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Yan Ma. A scholar is included among the top collaborators of Yan Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yan Ma. Yan Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gao, Hui, Xintong Yang, Xueli Liu, et al.. (2025). Pubertal low dose exposure to benzophenone-3 (BP-3) alters murine mammary stem cell functions. Ecotoxicology and Environmental Safety. 292. 117982–117982. 1 indexed citations
2.
3.
Jin, Wenbin, et al.. (2024). A drug-drug co-amorphous system for highly improved solubility of breviscapine: an experimental and computational study. Scientific Reports. 14(1). 31183–31183. 2 indexed citations
4.
Wang, Yuhang, Jinbo Li, Jiang Yu, et al.. (2023). Liposomal Nanodrug Based on Norcantharidin Derivative for Increased in Vivo Activity. AAPS PharmSciTech. 24(5). 118–118. 3 indexed citations
5.
Chen, Ping, Yaohui Wang, Ruochen Dong, et al.. (2022). Pharmacokinetic Evaluation of Intravenous Vitamin C: A Classic Pharmacokinetic Study. Clinical Pharmacokinetics. 61(9). 1237–1249. 24 indexed citations
6.
Lin, Jianqing, Erica Palmer, Christian Zevallos‐Delgado, et al.. (2021). Phase I Study of Entinostat in Combination with Enzalutamide for Treatment of Patients with Metastatic Castration-Resistant Prostate Cancer. The Oncologist. 26(12). e2136–e2142. 12 indexed citations
7.
Lin, Jianqing, et al.. (2021). Phase I study of entinostat in combination with enzalutamide for treatment of patients with castration-resistant prostate cancer.. Journal of Clinical Oncology. 39(6_suppl). 96–96. 2 indexed citations
8.
9.
Ma, Yan, et al.. (2020). Delivery of Platinum(IV) Prodrugs via Bi2Te3 Nanoparticles for Photothermal–Chemotherapy and Photothermal/Photoacoustic Imaging. Molecular Pharmaceutics. 17(9). 3403–3411. 21 indexed citations
10.
Ma, Yan, Ping Chen, Jeanne Drisko, et al.. (2020). Pharmacological ascorbate induces ‘BRCAness’ and enhances the effects of Poly(ADP‑Ribose) polymerase inhibitors against BRCA1/2 wild‑type ovarian cancer. Oncology Letters. 19(4). 2629–2638. 16 indexed citations
11.
Song, Haiqin, Zhiqiang Yu, Minhua Zheng, et al.. (2018). Carboplatin prodrug conjugated Fe3O4 nanoparticles for magnetically targeted drug delivery in ovarian cancer cells. Journal of Materials Chemistry B. 7(3). 433–442. 28 indexed citations
12.
Ma, Yan, Yuhua Wang, Yuhua Wang, et al.. (2017). Extreme low dose of 5-fluorouracil reverses MDR in cancer by sensitizing cancer associated fibroblasts and down-regulating P-gp. PLoS ONE. 12(6). e0180023–e0180023. 15 indexed citations
13.
Xiong, Jian, Zhichao Zhang, Rui Sun, & Yan Ma. (2017). Curcumin combined with electroacupuncture promotes the expression of brain-derived neurotrophic factor and nerve growth factor after cerebral infarction. Zhonghua wuli yixue zazhi. 39(3). 170–174. 1 indexed citations
14.
15.
Ma, Yan. (2014). Research Progress of Hyperuricemia Animal Model. Liaoning Zhongyiyao Daxue xuebao. 2 indexed citations
16.
Pessetto, Ziyan Y., et al.. (2014). Drug Repurposing Identifies a Synergistic Combination Therapy with Imatinib Mesylate for Gastrointestinal Stromal Tumor. Molecular Cancer Therapeutics. 13(10). 2276–2287. 32 indexed citations
17.
Wang, Yandong, et al.. (2014). Ocular Pharmacokinetics of Naringenin Eye Drops Following Topical Administration to Rabbits. Journal of Ocular Pharmacology and Therapeutics. 31(1). 51–56. 14 indexed citations
18.
19.
Yu, Jun, Yan Ma, Jeanne Drisko, & Qi Chen. (2013). Antitumor Activities of Rauwolfia vomitoria Extract and Potentiation of Carboplatin Effects Against Ovarian Cancer. Current Therapeutic Research. 75. 8–14. 44 indexed citations
20.
Ma, Yan. (2006). The Applying Study on the Neonate Screening TSH Cut-off. Zhongguo fuyou baojian. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yu Ishima Breakdown of academic impact, for papers by Barbara Marengo Breakdown of academic impact, for papers by Yi Feng Breakdown of academic impact, for papers by Yongmei Xie Breakdown of academic impact, for papers by Yunxiang Zhou Breakdown of academic impact, for papers by Francesca Re Breakdown of academic impact, for papers by Heather Hatcher Breakdown of academic impact, for papers by Kaoxiang Sun Breakdown of academic impact, for papers by Hongmei Li Breakdown of academic impact, for papers by Chiara Martinelli
Rankless by CCL
2026